These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Identification of renal natriuretic peptide receptor subpopulations by use of the non-peptide antagonist, HS-142-1. Rutherford RA; Matsuda Y; Wilkins MR; Polak JM; Wharton J Br J Pharmacol; 1994 Nov; 113(3):931-9. PubMed ID: 7858888 [TBL] [Abstract][Full Text] [Related]
9. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor. Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060 [TBL] [Abstract][Full Text] [Related]
10. Stable expression of natriuretic peptide receptors: effects of HS-142-1, a non-peptide ANP antagonist. Ohyama Y; Miyamoto K; Morishita Y; Matsuda Y; Saito Y; Minamino N; Kangawa K; Matsuo H Biochem Biophys Res Commun; 1992 Nov; 189(1):336-42. PubMed ID: 1360206 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide (ANP) antagonist of microbial origin. II. Restoration by HS-142-1 of ANP-induced inhibition of aldosterone production in adrenal glomerulosa cells. Oda S; Sano T; Morishita Y; Matsuda Y J Pharmacol Exp Ther; 1992 Oct; 263(1):241-5. PubMed ID: 1328608 [TBL] [Abstract][Full Text] [Related]
12. Different effect of ATP on ANP receptor guanylyl cyclase in spontaneously hypertensive and normotensive rats. Woodard GE; Zhao J; Rosado JA Acta Physiol (Oxf); 2006; 188(3-4):195-206. PubMed ID: 17054659 [TBL] [Abstract][Full Text] [Related]
13. Cyclosporine impairs the guanylyl cyclase activity of the natriuretic peptide receptor in the glomerulus. Kook H; Kim SW; Kang SY; Kim SZ; Kim JH; Choi KC; Lee J; Cho KW; Baik YH Pharmacol Res; 2000 Nov; 42(5):435-41. PubMed ID: 11023705 [TBL] [Abstract][Full Text] [Related]
15. Effects of isatin on atrial natriuretic peptide-mediated accumulation of cGMP and guanylyl cyclase activity of PC12 cells. Medvede AE; Abakumova OYu ; Podobed OV; Tsvetkova TA; Sandler M; Glover V Life Sci; 2001 Aug; 69(15):1783-90. PubMed ID: 11665840 [TBL] [Abstract][Full Text] [Related]
16. Rat renal preglomerular vessels, glomeruli and papillae do not express detectable quantities of B-type natriuretic peptide receptor. de Leon H; Bonhomme MC; Garcia R J Hypertens; 1994 May; 12(5):539-48. PubMed ID: 7930554 [TBL] [Abstract][Full Text] [Related]
17. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor. Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440 [TBL] [Abstract][Full Text] [Related]
18. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors. Wada A; Tsutamoto T; Matsuda Y; Kinoshita M Circulation; 1994 May; 89(5):2232-40. PubMed ID: 7910118 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of Ca(2+) on ATP-mediated stimulation of NPR-A-coupled guanylyl cyclase in renal glomeruli from spontaneously hypertensive and normotensive rats. Woodard GE; Zhao J; Rosado JA J Physiol Pharmacol; 2006 Sep; 57(3):359-73. PubMed ID: 17033090 [TBL] [Abstract][Full Text] [Related]
20. Characterization and regulation by protein kinase C of renal glomerular atrial natriuretic peptide receptor-coupled guanylate cyclase. Ballermann BJ; Marala RB; Sharma RK Biochem Biophys Res Commun; 1988 Dec; 157(2):755-61. PubMed ID: 2904814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]